Paraquat Lawsuit Settlement Amounts and Updates

Nguyen Injury Lawyer is currently accepting Paraquat cases in all 50 states. This page offers the latest information and updates regarding Paraquat lawsuits in both state and federal courts. We also provide our analysis of the litigation’s trajectory and estimated settlement amounts for viable Paraquat claims.

Individuals who have developed Parkinson’s disease due to Paraquat exposure are seeking clarity on the potential settlement amounts they might receive in a Paraquat lawsuit.

The projected Paraquat settlement amounts are subject to change as the litigation progresses. Nguyen Injury Lawyer will regularly update this page with revised payout estimates.

If you believe you have a potential claim, it’s crucial to prepare your case before any Paraquat settlement is reached. Contact Nguyen Injury Lawyer today at XXX-XXX-XXXX for a free online consultation or visit our contact page at https://www.nguyeninjurylawyer.com/contact.

Paraquat Lawsuit Updates 2026

Momentum Towards Funding Parkinson’s Research and Getting Rid of Paraquat

March 17, 2026

A recent national poll, coinciding with the 2026 Parkinson’s Policy Forum in Washington where over 350 Parkinson’s advocates from 49 states convened, reveals widespread bipartisan support for increased federal action on Parkinson’s disease.

The survey, conducted from March 3-5, 2026, among 1,000 registered voters, indicated that over three-quarters of voters support doubling federal funding for Parkinson’s research. Approximately two-thirds favor banning or restricting Paraquat due to its link to Parkinson’s risk, and around four in five desire a national strategy from the federal government to improve prevention, treatment, and care. The poll also revealed that 37 percent of voters report Parkinson’s affecting a family member or close friend, and 75 percent believe a cure is possible with increased research investment.

The advocacy efforts on Capitol Hill are centered on three key priorities: increasing NIH Parkinson’s research funding to $600 million annually, urging the EPA to finalize its Paraquat reassessment and suspend use of the herbicide, and implementing the long-awaited National Parkinson’s Project passed by Congress in 2024.

Syngenta to Stop Making Paraquat

March 10, 2026

Syngenta announced last week that it will cease global Paraquat production by June 2026. The company claims this decision is due to a shift toward newer technologies; however, this explanation is questionable.

Syngenta will likely never admit the obvious reason for this decision. Companies typically do not abandon flagship products, close manufacturing facilities, and rush to settle litigation if they anticipate winning. This move suggests the defendant has decided the legal battle is no longer worth pursuing.

Paraquat Deadlines Extended (Again)

February 6, 2026

The MDL judge has once again extended the stay on case-specific deadlines established in the January 2025 order through March 6, 2026, citing the ongoing settlement process. The judge has indicated that the issue will be revisited at that time to determine whether the stay should continue.

Hardly a Shocker – Syngenta and Chevron Settle First Case Headed to Trial

January 29, 2026

Syngenta and Chevron have quietly settled the first Paraquat Parkinson’s disease case scheduled for trial in Philadelphia.

The case, intended to be the first bellwether trial in the Philadelphia Paraquat Products Litigation, was resolved just before jury selection. The settlement terms remain confidential. According to the court, while this particular case has been resolved, the broader Paraquat mass tort is still active, with additional trials scheduled for April and later in the year.

Again, Syngenta and Chevron are clearly avoiding a jury trial in these cases, whether in Philadelphia or elsewhere. Their defense strategy has consistently involved aggressive motion practice and discovery. However, they understand the risks and are unwilling to face a jury with real evidence and witnesses.

The settlement details are confidential, but settling the first bellwether case at the last minute typically involves a significant premium. Avoiding a Philadelphia jury comes at a considerable cost.

Snow Pushes Back Paraquat Trial

January 26, 2026

The trial scheduled to begin today has been postponed due to snow. A new date has not yet been assigned.

MDL Case Count Reaches 8,257

January 16, 2026

As of January 2026, the Paraquat class action MDL includes 6,476 pending cases, with a total of 8,257 cases filed.

There are slightly over 1,600 Paraquat claims pending in Pennsylvania, with one case scheduled for trial on January 26th.

More Paraquat Lawsuit Updates Back to the Beginning of the Litigation

MDL Case Count Decreasing as Cases Settle

December 9, 2025

The number of pending cases in the Paraquat class action MDL decreased by 499 during November. This number is expected to continue to decline as more plaintiffs accept settlement offers.

MDL Case Count Update

November 3, 2025

With the stay extended through January, no new cases were added to the Paraquat MDL in the past month. However, 3 cases were dismissed, reducing the total number of pending cases to 6,442.

Stay Extended to… January

October 2, 2025

The MDL judge has extended the stay in the MDL in hopes that a settlement agreement can be reached. The stay for case-specific discovery will now continue through January 5, 2026, to facilitate the settlement process.

Latest MDL Case Count

October 1, 2025

There are currently 6,445 lawsuits in the MDL.

Stay Ends on Friday

September 24, 2025

The pause on advancing these cases will end on Friday, after which case-specific discovery should proceed unless a settlement is reached or the judge extends the stay further. The discovery hold began in May.

New Lawsuit

September 14, 2025

As we await news on whether the MDL will reach the settlement goal line, the number of lawsuits in the MDL has reached 6,362.

As settlement talks continue in the MDL, new lawsuits continue to be filed. In a new lawsuit filed Friday, a Georgia resident alleges she contracted Parkinson’s disease from prolonged exposure to Paraquat-based herbicides.

The complaint, filed directly in the MDL, alleges that the plaintiff regularly mixed and sprayed Paraquat while performing landscaping work from approximately 2008 to 2017, resulting in direct skin contact on numerous occasions. The plaintiff claims she was never informed that exposure to Paraquat, even when used as instructed, could be harmful.

MDL Case Count

September 10, 2025

A New York Times article today highlights the growing evidence that Paraquat exposure is contributing to America’s Parkinson’s crisis.

The article cited newly uncovered company records revealing that manufacturers were aware decades ago that the herbicide harmed the nervous system, yet continued to aggressively market it while minimizing the risks. Scientists now describe Parkinson’s as a man-made epidemic largely driven by pesticides like Paraquat, and note that regulators in Europe, China, and dozens of other countries have banned the chemical.

The Times article reinforces the claims made in lawsuits all along: Paraquat is dangerous, and the companies that profited from it should be held accountable for the consequences.

What Is the Latest on the Paraquat MDL Settlement?

August 12, 2025

Judge Nancy Rosenstengel has extended the stay on all case-specific deadlines in the Paraquat MDL until September 26, 2025, leaving three bellwether cases in a state of limbo. This marks the third such pause since April, when the parties announced a settlement in principle to resolve thousands of Parkinson’s disease claims against Syngenta and Chevron.

While much of the settlement framework is in place, progress has slowed due to objections or resistance to certain terms from some plaintiff firms, preventing full agreement.

If the settlement is not finalized by late September, case-specific discovery will resume, with the first bellwether trial still tentatively scheduled for October 14, 2025, and a second for April 6, 2026. However, it is likely the deal will be resolved before then.

Why Weeding Out Weak Paraquat Lawsuits Benefits You

August 8, 2025

There is considerable discussion in the Paraquat MDL regarding the dismissal of certain cases. Some members of the defense bar, and even a few on the plaintiffs’ side, have criticized the filing practices of some firms.

However, the validity of the underlying Parkinson’s disease claims is not in question. The MDL is functioning as intended by identifying and removing cases that do not meet the required evidentiary standards.

Judge Rosenstengel has consistently dismissed or set aside claims that should never have been filed, enabling the litigation to focus on legitimate cases. As we have maintained, this benefits plaintiffs with genuine and viable claims. For legitimate Paraquat plaintiffs, the narrowing of the MDL is not a setback but a crucial step toward a more successful resolution.

Pennsylvania Paraquat Docket Rises to Over 1,100

July 28, 2025

While the MDL appears to be progressing toward a settlement, the Pennsylvania Paraquat litigation has grown to over 1,100 lawsuits.

For Paraquat victims considering filing a claim, it’s essential to understand that you do not need to reside in Pennsylvania (or have been exposed to Paraquat there) to participate in this growing docket. Pennsylvania law currently permits individuals from outside the state to file lawsuits in the Philadelphia Court of Common Pleas, even if their exposure occurred elsewhere.

This is not a loophole, but rather a legal strategy employed by many Paraquat lawyers to avoid the delays and uncertainty associated with the federal MDL. The Philadelphia court has experience managing complex mass torts and is moving forward efficiently, with a dedicated judge and an established framework for resolving these cases. This combination of speed, structure, and judicial experience makes it an attractive venue for many out-of-state plaintiffs seeking to advance their claims without being caught in a federal backlog.

Effort to Kick Cases Out of Philadelphia

July 17, 2025

Philadelphia Paraquat lawsuits continue to proceed. A Philadelphia state court judge rejected an attempt by Syngenta and Chevron to remove cases from the city’s Paraquat mass tort docket.

The companies argued that plaintiffs residing outside of Pennsylvania should refile their claims elsewhere. The motion questioned the court’s ability to manage such comprehensive litigation. The court rejected the motion.

Paraquat MDL Judge Dismisses 116 Cases for Missed Deadlines

June 16, 2025

The court has dismissed 116 lawsuits in the Paraquat MDL for failing to submit the required Plaintiff Assessment Questionnaires, following the detailed process outlined in Case Management Order No. 10. Plaintiffs were given multiple opportunities to comply, including formal notices and grace periods, but ultimately failed to meet their obligations.

One plaintiff was excused from dismissal after demonstrating that communication issues had caused the delay, and the court determined that dismissal would only result in the case being refiled. The ruling underscores a key reality in mass tort litigation: claimants who miss deadlines will not be eligible for a settlement. However, the primary issue is that many of these claims were not viable from the outset.

Make America Healthy Again Disappoints on Paraquat

May 22, 2025

Surprisingly, Paraquat was not included in the Make America Healthy Again report on pesticides, despite RFK, Jr.’s extensive involvement in the Paraquat issue.

The lobbyists at Chevron and Syngenta deserve recognition for this omission.

Heading Toward Settlement in the MDL

April 15, 2025

On April 14, 2025, the lawyers filed a joint motion requesting that the Seventh Circuit hold their appeal in abeyance. The parties informed the Court that they had entered into a signed settlement framework that could resolve this case and many others in the MDL.

Because this potential resolution could eliminate the need for appellate review, the parties believe a stay would promote judicial economy. Judge Rosenstengel has no objection to the request.

Paraquat Litigation Updates

Attorneys in the Paraquat MDL have requested a stay pending settlement discussions. They intend to submit a joint status report 60 days after the Court’s stay order. Depending on the progress of settlement talks, they will either dismiss the appeal or resume litigation.

New Florida Paraquat Lawsuit

January 22, 2025: A new Paraquat lawsuit has been filed in the MDL by a Florida man alleging that his exposure to Paraquat caused him to develop Parkinson’s disease. According to the complaint, the plaintiff was regularly exposed to Paraquat from 2013 to 2019 while maintaining property in Hilliard, Florida. The plaintiff mixed, applied, and cleaned Paraquat during this time, resulting in significant contact with the chemical.

The plaintiff, a retired schoolteacher, used Paraquat for property maintenance, including spraying it on their land. The lawsuit states that the plaintiff was exposed to Paraquat through inhalation, skin absorption, and ingestion of spray droplets. They were diagnosed with Parkinson’s disease in August 2020 but only later realized the connection between the diagnosis and Paraquat exposure. The plaintiff’s spouse has also joined the lawsuit, claiming loss of consortium due to the disease’s impact on their marriage. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact for a free consultation.

Potential Impact of RFK Jr. on Paraquat Litigation

December 3, 2024: The potential confirmation of Robert F. Kennedy, Jr. as Secretary of Health and Human Services (HHS) could significantly impact Paraquat lawsuits linking the herbicide to Parkinson’s disease, given his history of advocating against toxic chemical exposure. This could lead to earlier and higher Paraquat settlements.

His leadership might encourage federal agencies such as the FDA, EPA, and CDC to more closely examine the health risks of Paraquat and potentially reconsider regulations surrounding its use. Kennedy’s position could also support plaintiffs in Paraquat lawsuits by increasing public awareness and validating claims of manufacturer negligence. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact for a free consultation.

MDL Selects Replacement Bellwether Cases

November 7, 2024: Judge Rosenstengel issued an order this summer identifying ten member cases for case-specific discovery in the Paraquat MDL. These cases were being prepared for the first Paraquat trials in the MDL.

After two plaintiffs voluntarily dismissed their complaints, the Court has selected two replacement cases to maintain the planned timeline:

• Anderson v. Syngenta Crop Protection, LLC, et al. (Case No. 3:23-pq-01712-NJR): The plaintiff operated multiple farms in Vergennes, Illinois, and was regularly exposed to Paraquat from around 1980 to 2012 through inhalation, ingestion, or skin absorption. During this time, the pesticide was widely sold to farmers and businesses in Illinois and applied nearby using ground-based and aerial spraying methods. In 2010, the plaintiff was diagnosed with Parkinson’s disease.
• Powrie v. Syngenta Crop Protection, LLC, et al. (Case No. 3:21-pq-00710-NJR): The plaintiff, a resident of Port Jervis, New York, worked as a licensed Paraquat applicator in New York, New Jersey, and Pennsylvania. During this time, he frequently mixed, loaded, applied, and cleaned paraquat products manufactured and sold by the defendants. He was diagnosed with Parkinson’s four years ago.

These replacement cases are subject to the same discovery timelines and due dates as the original selections. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact for a free consultation.

Bellwether Cases Dismissed After Expert Exclusion

April 17, 2024: The MDL judge dismissed the four bellwether lawsuits after excluding the testimony of the plaintiff’s key expert on general causation, Dr. Martin Wells.

This decision renders those four cases moot because, without this testimony, plaintiffs could not establish the necessary causal link for their claims. The court also granted a summary judgment for the defendants, concluding that the plaintiffs’ claims were untenable without the expert’s testimony.

The court plans to proceed quickly by selecting a new group of cases for trial. The judge has directed the parties to choose 16 new cases for limited fact discovery by a specified deadline.

Each party has a specific allocation for case selection: plaintiffs will choose eight cases, while Chevron and Syngenta will select four each. The selected cases must meet specific eligibility criteria, including being filed on or before the date of the judge’s order and not having a materially deficient Plaintiff Assessment Questionnaire.

After the selections are submitted, the court will issue a Case Management Order outlining a discovery schedule and setting trial dates. The attorneys at Nguyen Injury Lawyer are committed to finding the best experts to support the science linking Paraquat and Parkinson’s disease. Contact us at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact for a free consultation.

2017 Illinois Settlements Revealed

March 22, 2024: In 2017, Syngenta faced lawsuits in state court from victims diagnosed with Parkinson’s disease. Syngenta settled these lawsuits confidentially, totaling $187.5 million. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact for a free consultation.

New Study Strengthens Paraquat-Parkinson’s Link

March 7, 2024: A new Paraquat study supports the premise that Paraquat exposure can cause Parkinson’s disease. The study found that those with Parkinson’s disease lived and worked closer to areas where Paraquat was used compared to those without Parkinson’s. Working near Paraquat every year significantly increased the risk of developing PD. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact for a free consultation.

Paraquat Parkinson’s Disease Lawsuit FAQs

As we move further into 2025, the Paraquat litigation is generating significant anticipation. After years of legal battles and mounting evidence linking this herbicide to Parkinson’s disease, we are approaching a critical point. The first Paraquat trial is scheduled for June in Philadelphia.

Chevron and Syngenta face increasing pressure. With a jury trial approaching, the risks are substantial. Juries tend to favor individuals over corporations in these cases, especially when evidence suggests corporate negligence. The unpredictability of a courtroom battle is a concern for these companies.

The key question is whether Chevron and Syngenta will settle just this one case or negotiate a global settlement to resolve the majority of these lawsuits. Nguyen Injury Lawyer anticipates and hopes for the latter, as it is in the companies’ best interest to resolve this litigation quickly. Contact us at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact for a free consultation.

The changing political landscape adds urgency. With Robert F. Kennedy Jr. potentially leading HHA, discussions around toxic chemicals and corporate accountability are expected to intensify. If this case results in a significant verdict against Chevron and Syngenta, it could lead to changes in pesticide regulation.

Below are frequently asked questions about the Paraquat litigation:

When will the Paraquat lawsuit be settled?

There was a tentative settlement in the MDL in 2025. A year later, we are waiting for this deal to be finalized, along with the resolution of state court claims.

How long does a Paraquat settlement take?

The timeframe for a Paraquat lawsuit settlement is unlikely to be very case-specific. Claimants with viable claims at the time of a global settlement will likely be eligible. Once a global settlement is reached, it will take several months to over a year for claimants to receive their Paraquat settlement check. One of the bottlenecks is assigning payouts to individual victims through a points system.

What is the status of the Paraquat lawsuit?

A settlement is pending in the MDL, awaiting finalization. Meanwhile, state court claims are progressing, with the first Paraquat lawsuit set to take place in Philadelphia this fall.

What are the potential Paraquat lawsuit settlement amounts?

While only one settlement has been officially announced, estimates suggest that settlements could range from $100,000 to over $1,500,000 per plaintiff, depending on the severity of their illness and supporting medical evidence. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact for a free consultation.

Do I qualify for a Paraquat Parkinson’s lawsuit?

You may qualify to file a Paraquat Parkinson’s lawsuit if:

• You were exposed to Paraquat through farming, landscaping, or living near agricultural areas.
• You have been diagnosed with Parkinson’s disease or a related neurological disorder.
• You can provide evidence of exposure, such as employment records or medical history.

What’s the latest Paraquat lawsuit update in 2026?

This page provides the latest Paraquat lawsuit updates. Nguyen Injury Lawyer is committed to keeping you informed about the current status of this litigation. Contact us at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact for a free consultation.

Paraquat Lawsuit

Hundreds of farmworkers and people who worked near oil tanks and railroads have filed lawsuits alleging that occupational exposure to the industrial herbicide paraquat (grameoxone) caused or contributed to the plaintiff’s development of Parkinson’s disease.

There are now nearly 6,000 Paraquat lawsuits in the MDL, and many more are being filed in state court. A Parkinson’s disease class action MDL has already been established to accommodate them. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact for a free consultation.

About the Paraquat Lawsuits

Paraquat is an industrial-strength herbicide that has been around since the 1960s. It is used to control weeds and grasses in agricultural areas. It is also used as a defoliant, removing leaves from trees and plants. Some farmers will use Paraquat as a desiccant, too, to keep the crops dry and stable. Chevron started selling Paraquat in the U.S. in 1964.

This chemical is highly toxic. A teaspoon can be fatal. This has led most European countries to ban it outright. In the United States, however, Paraquat is not banned and is widely utilized by large commercial farmers. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact for a free consultation.

Paraquat Lawsuits and Parkinson’s Disease

Research indicates that prolonged exposure to Paraquat may contribute to the development of early-onset Parkinson’s disease. Studies suggest that agricultural workers with long-term Paraquat exposure have a significantly elevated risk of developing Parkinson’s. Likewise, individuals residing near farms where Paraquat is used have also shown higher rates of the disease.

Syngenta, a Swiss agrochemical company, manufactures Paraquat. Evidence suggests that Syngenta may have been aware of the causal relationship between Paraquat and Parkinson’s for years but deliberately concealed this information. Farm workers exposed to Paraquat who have been diagnosed with Parkinson’s are now pursuing product liability lawsuits against Syngenta and its U.S. distributors. Nguyen Injury Lawyer is here to help.

Thousands of Paraquat Parkinson’s lawsuits have been filed, leading to the creation of a Paraquat MDL (Paraquat Prod. Liab. Lit., MDL 3004) in the Southern District of Illinois to consolidate and streamline the handling of these claims.

News headlines include:

• New calls to ban Paraquat in the UK over Parkinson’s disease risk
• Paraquat Litigation Should Result in a “Global Settlement”

The Paraquat Parkinson’s disease lawsuits are well into the multidistrict litigation process, and the likely outcome is becoming clearer. With all federal claims consolidated before a single judge, the MDL has undergone years of coordinated discovery focused on the scientific evidence linking Paraquat exposure to Parkinson’s disease. New cases continue to be added, ensuring that thousands of claims move forward together. Contact Nguyen Injury Lawyer for a free consultation: XXX-XXX-XXXX.

The next major step is the bellwether trial phase, where a select group of representative lawsuits will be tried before juries. These bellwether verdicts will provide a clear indication of how juries perceive the evidence against Syngenta and the other defendants. Favorable verdicts for the plaintiffs would exert significant pressure on the companies to resolve the remaining claims. It is anticipated that a global settlement will be reached in both the MDL and the increasing state court dockets before a single trial occurs. A trial scheduled for January 2026 will be a key indicator.

In mass tort litigation, global settlement negotiations typically commence at this stage. A global settlement is a structured agreement that provides compensation to all eligible victims, with amounts varying based on factors like injury severity, age, and the strength of the evidence in each case. Given the established scientific record and the extent of exposure, Paraquat litigation appears to be moving in this direction. If you believe you have been affected, please reach out to Nguyen Injury Lawyer via our contact page: https://www.nguyeninjurylawyer.com/contact.

Key Variables for a Paraquat Lawsuit Settlement

The central issue in the Paraquat Parkinson’s disease lawsuits revolves around the appropriate amount of settlement compensation. Syngenta, Chevron, and other co-defendants are striving to minimize settlement payouts.

Individual Paraquat settlement amounts will depend on several factors, including:

• The number of Paraquat claims filed and consolidated into the MDL.
• The strength of the scientific evidence linking Paraquat exposure to Parkinson’s disease in plaintiffs.
• The outcomes of the initial bellwether trials.

Estimated Paraquat Lawsuit Settlement Payout Amount

Despite these variables, Nguyen Injury Lawyer can offer an estimated range for individual Parkinson’s disease settlement payouts. This estimation is based on settlement payouts in prior mass tort cases and an assessment of the likelihood that a jury would find the Paraquat defendants liable. Our attorneys also consider settlement compensation for Parkinson’s disease in tort cases generally. Contact us today: XXX-XXX-XXXX.

Based on these comparisons, Nguyen Injury Lawyer estimates the likely settlement payouts for Paraquat claims as follows:

Settlement Tier	Estimated Settlement
Tier I	$400,000 – $1,000,000+
Tier II	$150,000 – $300,000
Tier III	$20,000 – $150,000

These figures represent expected Paraquat settlement amounts, not potential trial values. A successful verdict in an individual Paraquat lawsuit could exceed $10 million, with the possibility of additional punitive damages. Nguyen Injury Lawyer is ready to fight for your rights.

In comparison, successful verdicts in Roundup lawsuits have averaged well over $500 million. In the 3M earplug lawsuit, involving hearing-related injuries, the average individual jury payout exceeds $10 million. Given that Parkinson’s disease is a far more serious condition, an estimated average jury compensation payout of $10 million may be conservative.

We anticipate that the average Paraquat settlement will fall within the $600,000 to $900,000 range, although the MDL average may be lower. The specific position within this range will depend on the viability threshold set by the defendants, who may choose to settle all claims or only the strongest cases. Our attorneys believe the latter is more likely, which would reduce the average payout.

Looking ahead to 2026, we anticipate that victims will receive more substantial Paraquat settlements than currently predicted, although the MDL average will be affected by weaker cases. Many cases are expected to exceed the million-dollar settlement mark. If you or a loved one has been affected by Paraquat exposure, reach out to Nguyen Injury Lawyer at https://www.nguyeninjurylawyer.com.

These projections are more applicable to state court cases than the MDL. Cases in state court, particularly in Pennsylvania, are expected to have higher average per-person settlement amounts than Paraquat lawsuits filed in the MDL.

Settlement Amounts in Lawsuits Involving Parkinson’s Disease

Another point of comparison for valuing Paraquat cases is the settlement value of other tort cases where Parkinson’s disease was the plaintiff’s primary injury.

Parkinson’s disease is challenging to value due to its relative infrequency in personal injury claims. Camp Lejeune Parkinson’s disease lawsuits are also being filed, but there are limited settlement amounts available (average settlement: $325,000) in that litigation so far.

Tardive dyskinesia, a similar condition, may offer a comparable settlement marker in tort cases. Nguyen Injury Lawyer has experience in these cases and can assess settlement amounts and jury payouts for tardive dyskinesia to provide insight into potential Parkinson’s disease settlement amounts.

Examples of relevant cases include:

• Watters v Qin (Arizona 2024) $335,669 Verdict: The plaintiff alleged that the stress of the defendant’s harassment exacerbated her pre-existing Parkinson’s disease.
• Axe v Spring Meadows (Pennsylvania 2018) $215,000 Settlement: A 73-year-old plaintiff alleged that he developed tardive dyskinesia from medications given to him by a nursing home.
• Plaintiff v Defendant (New York 2017) $1,400,000 Settlement: A plaintiff in her mid-30s developed tardive dyskinesia from antipsychotic medication used to treat her bipolar disorder and sued the prescribing doctor.
• Soref v Agresti (Florida 2017) $569,000 Verdict: A female in her mid-20s with a history of drug abuse claimed that bipolar drugs caused her to develop tardive dyskinesia.
• Tamaraz v Lincoln Electric (Ohio 2007) $20,500,000 Verdict: A welding rod product liability lawsuit alleged that the plaintiff developed Parkinson’s disease from exposure to manganese in welding rods. The jury awarded $17.5 million to him and $3 million to his wife. This verdict highlights the potential for substantial compensation in Parkinson’s disease cases.

These cases, particularly the welding rod case, suggest the type of verdict that might be seen in Paraquat bellwether trials. These compensation awards support the settlement payout valuation estimates above. Call Nguyen Injury Lawyer today for your free consultation: XXX-XXX-XXXX.

Paraquat Lawsuits Can Be Filed Decades After the Plaintiff’s Exposure

If you have been recently diagnosed with Parkinson’s disease that may be linked to Paraquat exposure, you can still file a Paraquat lawsuit, even if the exposure occurred years or decades ago. All states have statutes of limitations that set deadlines for filing civil tort actions, such as product liability claims. The applicable statute of limitations period for a tort claim typically ranges from 1 to 7 years, depending on the state.

However, the statute of limitations period does not begin until the plaintiff knew or should have known that they had a claim. In a Paraquat lawsuit, this means that the statute of limitations period would not begin until the plaintiff knew or should have known that they had Parkinson’s disease and that it may have been caused by Paraquat exposure.

The connection between Paraquat exposure and Parkinson’s disease is not something that a reasonable person would be expected to know, especially given that the companies that manufactured and sold Paraquat deliberately failed to warn about this link. Many plaintiffs in Paraquat and Parkinson’s disease litigation are bringing claims based on exposure that occurred long ago. Nguyen Injury Lawyer can help you understand your options. Visit our website: https://www.nguyeninjurylawyer.com.

Link Between Paraquat and Parkinson’s Disease

Parkinson’s disease is a progressive neurodegenerative disorder of the brain that primarily affects the motor system, which controls movement.

The characteristic symptoms of Parkinson’s disease are its primary motor symptoms: resting tremor, bradykinesia (slowness in voluntary movement and reflexes), rigidity, and postural instability. Currently, there is no cure for Parkinson’s disease. Existing treatments only temporarily and partially relieve motor symptoms and do not slow or stop the disease’s progression. These treatments also have undesirable side effects with long-term use.

Paraquat is a toxic chemical that is an effective plant killer. However, the same properties that make Paraquat toxic to plant cells also make it highly damaging to human nerve cells, posing a significant risk to anyone who uses it.

Oxidative stress is a major factor, if not the primary cause, of the degeneration and death of dopaminergic neurons, which is the main pathophysiological cause of Parkinson’s disease. Paraquat is designed to injure and kill plants by creating oxidative stress, which causes or contributes to the degeneration and death of plant cells. Similarly, Paraquat injures and kills animals by creating oxidative stress, leading to the degeneration and death of animal cells.

The causal link between Paraquat and Parkinson’s disease is well-established. Hundreds of animal studies involving various routes of exposure have found that Paraquat creates oxidative stress that results in pathophysiology consistent with that seen in human Parkinson’s disease.

Numerous epidemiological studies have also found an association between Paraquat exposure and Parkinson’s disease, including multiple studies finding a two-to-five-fold or greater increase in the risk of Parkinson’s disease in populations with occupational exposure to Paraquat compared to populations without such exposure.

You do not need to work on a farm to have a viable Paraquat lawsuit. Researchers in an article in the American Journal of Epidemiology found that exposure to Paraquat or Maneb.

Paraquat Exposure and Parkinson’s Disease Research

Research has indicated a potential connection between Paraquat exposure and an increased risk of developing Parkinson’s disease. For instance, one study revealed that individuals residing within 500 feet of areas where Paraquat was used experienced a 75% increase in the likelihood of developing Parkinson’s disease.

Below are key research articles concerning Paraquat exposure and Parkinson’s disease, along with summaries of their findings:

• Pezzoli, G., & Cereda, E. (2013). Exposure to pesticides or solvents and risk of Parkinson’s disease. Neurology, 80(22), 2035–2041. This study investigated the correlation between environmental exposures, including pesticides like Paraquat, and the risk of Parkinson’s disease. The findings suggested that exposure to pesticides was linked to a higher risk of Parkinson’s, especially in individuals with genetic predispositions. The research emphasizes the role of interactions between genes and environmental factors in the development of Parkinson’s disease.

• Berry, C., La Vecchia, C., & Nicotera, P. (2010). Paraquat and Parkinson’s disease. Cell Death & Differentiation, 17(7), 1115-1125. This study explored the role of pesticides in the development of Parkinson’s disease, suggesting that even brief exposure to certain chemicals could be “sufficient” to trigger the disease.

• Costello, S., et al. (2009). Parkinson’s disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. American journal of epidemiology, 169(8), 919-926. This research examined the connection between living near farms using pesticides and the risk of Parkinson’s disease. The study found that living within 500 feet of farms using Paraquat and maneb increased the risk of Parkinson’s by 75%. Younger individuals (under 60) were found to be at a significantly higher risk. The study concluded that exposure to Paraquat and maneb, either separately or together, significantly elevated the risk of Parkinson’s.

• Di Monte, D.A. (2003). The environment and Parkinson’s disease: Is the nigrostriatal system preferentially targeted by neurotoxins? The Lancet Neurology, 2(9), 531-538. This report suggested that a multidisciplinary approach to studying the causes of Parkinson’s disease would help determine if environmental factors could contribute to the disease.

• Firestone, J. A., et al. (2005). Pesticides and Risk of Parkinson’s Disease: A Population-Based Case-Control Study. Archives of Neurology, 62(1), 91-95. This study investigated the relationship between pesticide exposure and Parkinson’s disease. Researchers interviewed 250 Parkinson’s patients and 388 individuals without Parkinson’s, assessing their self-reported pesticide exposures and categorizing them by occupation. The study revealed that pesticide workers were more likely to develop Parkinson’s compared to crop, animal, and dairy farmers, aligning with findings from other studies that linked pesticides to Parkinson’s.

• Mandel, J. S., Adami, H. O., & Cole, P. (2012). Paraquat and Parkinson’s disease: an overview of the epidemiology and a review of two recent studies. Regulatory Toxicology and Pharmacology, 62(2), 385-392. This report analyzed two studies that assessed the link between pesticide exposure and Parkinson’s disease. The researchers noted that the studies had design limitations, including small sample sizes of exposed patients, and reported inconsistent results. They concluded that these studies did not definitively prove a connection between pesticides and Parkinson’s and that more robust research was necessary.

• McCormack, A. L., et al. (2002). Environmental risk factors and Parkinson’s disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiology of Disease, 10(2), 119-127. This study explored whether Paraquat exposure induced Parkinson’s disease symptoms in mice. Mice injected with Paraquat experienced dopaminergic neuron death, a characteristic symptom of Parkinson’s disease. The researchers concluded that these findings indicate that Paraquat neurotoxicity elicits a significant physiological response related to Parkinson’s.

• Stephenson, J. (2000). Exposure to home pesticides linked to Parkinson’s disease. JAMA, 283(23), 3055-3056. This article discussed the connection between Parkinson’s disease and exposure to pesticides in and around homes and gardens.

• Stykel, M.G., et al. (2018). Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson’s disease. The FASEB Journal, 32(10), 5350-5364. This study examined how pesticide exposure disrupted cells in ways that resembled Parkinson’s-related mutations. The researchers concluded that their results were the first to identify a gene that caused mitochondrial transport deficits during pesticide exposure. One of the authors stated, “People exposed to these chemicals are at about a 250-percent higher risk of developing Parkinson’s disease than the rest of the population,” suggesting that Paraquat exposure may be a significant factor in the development of Parkinson’s disease for many individuals.

• Tanner, C. M., et al. (2011). Rotenone, Paraquat, and Parkinson’s disease. Environmental health perspectives, 119(6), 866-872. This study investigated the association between pesticides causing oxidative stress or mitochondrial dysfunction and Parkinson’s disease in humans. The researchers found that Paraquat and rotenone were linked to Parkinson’s.

• Uversky, V.N., et al. (2002). Synergistic effects of pesticides and metals on the fibrillation of α-synuclein: implications for Parkinson’s disease. Neurotoxicology, 23(4-5), 527-536. This study used a novel model to identify environmental factors and genetic susceptibilities that underlie idiopathic Parkinson’s disease. The researchers found that certain pesticides and metals induced conformational changes in alpha-synuclein and accelerated the formation of alpha-synuclein fibrils.

• Vaccari, C., et al. (2019). Paraquat and Parkinson’s disease: a systematic review and meta-analysis of observational studies. Journal of Toxicology and Environmental Health, Part B, 22(5-6), 172-202. This systematic review analyzed existing literature and meta-analyses on Paraquat exposure and Parkinson’s disease. While the researchers found that current data suggested a positive correlation between Paraquat exposure and Parkinson’s, they concluded that the evidence was not sufficient to establish a causal relationship and called for better-designed studies.

Consult a Nguyen Injury Lawyer About Paraquat Exposure

If you are considering a lawsuit related to Paraquat exposure and Parkinson’s disease, Nguyen Injury Lawyer is available to discuss your potential claim and explore your legal options. Contact our toxic exposure attorneys at XXX-XXX-XXXX or submit a contact form via our website at https://www.nguyeninjurylawyer.com/contact for a free consultation.